Methods of treating schizophrenia and other neuropsychiatric disorders
OwnerSteven A. GOLDMAN, Zhengshan LIUinventors
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to methods of restoring K+ uptake by glial cells in a subject. These methods involve administering, to the subject, a SMAD4 inhibitor under conditions effective to restore K+ uptake by said glial cells. The present disclosure is also directed to methods of treating or inhibiting the onset of a neuropsychiatric disorder in a subject. These methods involve administering, to a subject in need thereof, a SMAD4 inhibitor under conditions effective to treat or inhibit the onset of the neuropsychiatric disorder in the subject.
Claims27
A method of restoring K+ uptake by glial cells having impaired K+ channel function, said method comprising
- administering, to the glial cells having impaired K+ channel function, a SMAD4 inhibitor under conditions effective to restore K+ uptake by said glial cells.
The method of claim 8, wherein the neuropsychiatric disorder is schizophrenia.
A method of restoring K+ uptake by glial cells in a subject, said method comprising:
- selecting a subject having impaired glial cell K+ uptake, and
- administering, to the selected subject, a SMAD4 inhibitor under
- conditions effective to restore K+ uptake by said glial cells.
A method of treating or inhibiting the onset of a neuropsychiatric disorder in a subject, said method comprising:
- selecting a subject having or at risk of having a neuropsychiatric disorder, and
- administering, to the selected subject, a SMAD4 inhibitor under conditions effective to treat or inhibit the onset of the neuropsychiatric disorder in the subject.
-40. (canceled)
Dependencies are inferred from the claim text.